Addus HomeCare Corporation (NASDAQ:ADUS) Given Average Rating of “Moderate Buy” by Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have received an average recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokers that have covered the stock in the last year is $131.00.

Several analysts have recently weighed in on ADUS shares. Barclays lowered their price objective on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Weiss Ratings lowered shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 22nd. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Finally, Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st.

Addus HomeCare Price Performance

ADUS stock opened at $105.17 on Friday. The company’s 50 day moving average is $95.10 and its 200 day moving average is $101.31. The stock has a market cap of $1.96 billion, a price-to-earnings ratio of 19.44, a price-to-earnings-growth ratio of 1.44 and a beta of 0.88. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. Addus HomeCare has a 1-year low of $87.95 and a 1-year high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same period in the previous year, the business posted $1.42 earnings per share. Addus HomeCare’s revenue for the quarter was up 7.7% on a year-over-year basis. Sell-side analysts predict that Addus HomeCare will post 6.24 EPS for the current fiscal year.

Insider Activity

In other news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 966 shares of company stock valued at $90,168. 4.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. Royal Bank of Canada raised its stake in shares of Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock valued at $1,026,000 after purchasing an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Addus HomeCare by 6.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after purchasing an additional 2,952 shares during the last quarter. Jane Street Group LLC raised its position in Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC raised its position in Addus HomeCare by 44.7% in the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.